LORI RUMFIELD: Open Payments
NPI 1295084887 · MANCHESTER, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$370 in 21 payments from 13 companies in 2025. Trend: 2023 $158 · 2024 $13 · 2025 $370
Food & beverage: $370
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $62 |
| Verona Pharma, Inc. | 3 | $57 |
| Novo Nordisk Inc | 2 | $42 |
| Alkermes, Inc. | 2 | $36 |
| Vanda Pharmaceuticals Inc. | 1 | $32 |
| Lilly USA, LLC | 2 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: Ohtuvayre, VRAYLAR, ARISTADA, HETLIOZ, MOUNJARO, Wegovy, Kerendia, Dexcom G6 Transmitter.
Industry payments across OH — which companies pay providers there.
